A Phase II Study of Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
This is a multi-centre, open-label, Phase II clinical trial evaluating pembrolizumab in
combination with carboplatin/paclitaxel as a treatment in unresectable locally advanced or
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society